heat.

Health Evaluations & Applied Therapeutics | News & Intelligence on BioPharmaceutical Pricing & Access.

[heat. @heatinformatics]

The United States has the world's highest drug prices, by far | https://t.co/l2lh82sQ1V

[heat. @heatinformatics]

Six-figure price-tags for prescription drugs are increasingly common in the United States, with several products having passed the million dollar mark | https://t.co/s9vh2wjk1q

[heat. @heatinformatics]

The Top Biopharmaceutical Investors in the World | https://t.co/hkODwY8Kyb #Pharma #Biotech

[heat. @heatinformatics]

With the largest vaccination program in human history well underway, what are drug manufacturers charging for their COVID-19 vaccines? | https://t.co/XY6MohnVe5

[heat. @heatinformatics]

Seventy-eight percent of Americans worry the COVID-19 vaccine approval process is being driven by politics, not science | https://t.co/TXHcLqM8so

[heat. @heatinformatics]

If a “most favoured nation” approach were to be implemented, it would have no direct impact on the lion’s share of drug spending in America | https://t.co/Xp1DY5hUOZ

[heat. @heatinformatics]

A deadline set by U.S. President Trump for moving forward with an executive order to lower drug prices passed at midnight on Tuesday without any action so far from the White House | https://t.co/4kZ7uIiexI

[heat. @heatinformatics]

The #pharma industry is offering to cut prices for physician-administered drugs in Medicare Part B by 10 percent. The administration estimated its original plan to link payments to lower costs abroad would save 30 percent | https://t.co/LqF0xdYvyG

[heat. @heatinformatics]

Swiss #Pharma manufacturer Novartis has received U.S. FDA approval to repurpose an 11-year-old blood cancer drug against multiple sclerosis. First approved in 2009 under the brand name Arzerra for CLL, Kesimpta's WAC price for MS is $83,000 | https://t.co/FoZppMkltw

[heat. @heatinformatics]

About 14% of antibiotics in phase I trials are likely to win U.S. FDA approval. And, the Americans have only approved 15 antibiotics over the past decade, of which 5 are no longer available | https://t.co/jivayZpHpz

[heat. @heatinformatics]

China's Sinopharm has said its experimental vaccine could be ready for public use by the end of this year and cost no more than 1,000 yuan ($144.27) for two shots | https://t.co/J9HBEMoI8q

[heat. @heatinformatics]

Roche has priced Enspryng in the U.S. at a Wholesale Acquisition Cost of just under $220,000 for the first year (when 15 doses are needed) and $190,000 for subsequent years when 13 doses are required | https://t.co/6lAakoPCPb

[heat. @heatinformatics]

The 10 highest-selling drugs in the U.S. last year gave away more than $23 billion in rebates to insurance intermediaries, but still netted $50 billion in sales | https://t.co/gU0kyIvHH2

[heat. @heatinformatics]

The array of connections between lawmakers and the #pharma companies they regulate in America | @statnews https://t.co/WLAXkgwJm1

[heat. @heatinformatics]

The European nation has become the first country to require drug manufacturers to disclose data about public funding for any medicines during negotiations over pricing and reimbursement | https://t.co/oAKJdfj9OZ

[heat. @heatinformatics]

Roche uses 'weight-based' pricing approach on new Spinal Muscular Atrophy drug. The list price of Evrysdi will be based on weight until a patient reaches 44 pounds (20 kg) at about 6 years of age, at which point the price reaches a maximum of $340,000/yr | https://t.co/ldZUyzm9Vk

[heat. @heatinformatics]

New details are emerging about how much drugmakers are charging for coronavirus vaccines, with prices spanning from several dollars a dose to more than $70 for a regimen | https://t.co/8wHM20hNQT

[heat. @heatinformatics]

Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course | https://t.co/4fH7a70gEe

[heat. @heatinformatics]

Gilead set the list price of Tecartus at $373,000, the same as Yescarta (also made by Gilead) | https://t.co/jPCiz7L3rn

[heat. @heatinformatics]

One of the leading U.S. firms developing a coronavirus vaccine has awarded its executives stock options that could pay out tens of millions of dollars even if its efforts fail | https://t.co/sXlzWoCGjn